Nutrigenomics: DNA-based individualized nutrition

In the past decade, nutrition research has undergone an important shift from epidemiology and physiology to molecular biology, adipobiology and genetics, thus launching the science of nutrigenomics. To at molecular level study effects of nutrition on health and disease. The completion of several large genome projects has markedly altered the research agenda by drawing attention to the importance of genes in human nutrition. There has been a growing recognition that micronutrients and macronutrients can be potent dietary signals that influencethemetabolic pathways of cells and have an important role in the control of energy, vascular and neuronal homeostasis. Accordingly, nutrition researchers have increasingly started to recognize that gene-environment interactions can be implicated in the pathogenesis of lifestyle-related diseases, particularly cardiometabolic diseases, fatty liver diseases, cancers, and Alzheimer's disease. An adiponutrigenomic insight into life expectancy is also outlined. Overall, the present Dance Round focuses on a mater of nationwide importance for Bulgaria, a country at the epicenter of today's global healthquake, the obesity and related diseases.Biomedical Reviews 2006; 17: 117-122

Adipobiology of stem cell-based therapy: secretome insight

Stem from the promise of stem cells therapeutic potential for a number of diseases, the regenerative medicine is reaching enthusiastic proportions nowadays. Current therapies include drug treatment, lifestyle modification, organ transplantation, RNA interference "breakthrough technology", and stem cell-based therapy. Research on stem cells is a multiplex challenge provoking both the attention and the confusion of biologists, biotechnologists, medical specialists, and politicians. By integrating various approaches of transcriptomics, proteomics and metabolomics, current adipobiology has identified more than 100 secretory proteins that are produced by the adipose tissue. These proteins designated adipokines include growth factors, cytokines, chemokines, neuropeptides and hypothalamic hormones/releasing factors. In addition, the adipose tissue`s secretome contains steroid hormones, free fatty acids, prostaglandins, and endocannabinoinds. Moreover, adipose tissue is the source of adipose-derived stem cells (ADSC). Current interest in the ADSC stems from their multilineage differentiation potential, and ease of derivation in larger quantities using less invasive methods, compared with other stem cell types. The possible benefits of ADSC-based therapy may be mediated via cell proliferation/differentiation and/or paracrine mechanisms. The present review, focusing on adipose tissue secretory activity, also highlights the possible implication of ADSC in the therapy of various disorders, particularly neurodegenerative diseases, myocardial infarction and stroke, along with gut and liver diseases.Biomedical Reviews 2010; 21: 57-63

SOS for Homo sapiens obesus

Published on 1 December 1994 issue of Nature, the Jeffrey Friedman's discovery "gave leptin in the beginning" of the endocrine saga of adipose tissue. Onwards, studies on this tissue have enjoyed an explosive growth that conceptualized a novel field of research, adipobiology. Arguably, in the heart of adipobiology and adipopharmacology are studies focusing on the pathogenesis, prevention and therapy of cardiometabolic diseases (CMD) including atherosclerosis, hypertension, obesity, type 2 diabetes, metabolic syndrome (global cardiometabolic risk), and lipodystrophies.Adipobiology 2010; 2: 5-8

In the heart of adipobiology: cardiometabolic disease

Published on 1 December 1994 issue of Nature, the Jeffrey Friedman's discovery "gave leptin in the beginning" of the endocrine saga of adipose tissue. Onwards, studies on this tissue have enjoyed an explosive growth that conceptualized a novel field of research, adipobiology. Arguably, in the heart of adipobiology and adipopharmacology are studies focusing on the pathogenesis, prevention and therapy of cardiometabolic diseases (CMD) including atherosclerosis, hypertension, obesity, type 2 diabetes, metabolic syndrome (global cardiometabolic risk), and lipodystrophies.Biomedical Reviews 2009; 20: 1-5

The adipose tissue: a new member of the diffuse neuroendocrine system?

Adipose tissue is a sophisticated module, consisting of adipocytes and non-adipocyte cellular elements including stromal, vascular, nerve and immune cells. There is at present evidence that sharing of ligands and their receptors constitutes a molecular language of the human's body, which is also the case for adipose tissue and hypothalamus-pituitary gland. Historically, Nikolai Kulchitsky's identification of the enterochromaffin cell in 1897 formed the basis for the subsequent delineation of the diffuse neuroendocrine system (DNES) by Friedrich Feyrter in 1938. In DNES paradigm, the secretion of hormones, neuropeptides and neurotrophic factors is executed by cells disseminated throughout the body, for example, Kulchitsky (enterochromaffin) cells, testicular Leydig cells, and hepatic stellate cells. Here we propose that the adipose tissue might be a new member of DNES. Today (dnes, in Bulgarian), adipose tissue is "getting nervous" indeed: (i) synthesizes neuropeptides, neurotrophic factors, neurotransmitters, hypothalamic hormones/releasing factors and their receptors, (ii) like brain expresses endocannabinoids and amyloid precursor protein and, for steroidogenesis, the enzyme aromatase (P450arom), (iii) adipocytes may originate from the neural crest cells, and (iv) adipose-derived stem cells may differentiate into neuronal cells. Further molecular profiling of adipose tissue may provide new biological insights on its neuroendocrine potential. Overall this may frame a novel field of study, neuroadipobiology; its development and clinical application may contribute to the improvement of human's health.Adipobiology 2009; 1: 87-93

The Orbit and Mass of the Third Planet in the Kepler-56 System

While the vast majority of multiple-planet systems have their orbital angular momentum axes aligned with the spin axis of their host star, Kepler-56 is an exception: its two transiting planets are coplanar yet misaligned by at least 40 degrees with respect to their host star. Additional follow-up observations of Kepler-56 suggest the presence of a massive, non-transiting companion that may help explain this misalignment. We model the transit data along with Keck/HIRES and HARPS-N radial velocity data to update the masses of the two transiting planets and infer the physical properties of the third, non-transiting planet. We employ a Markov Chain Monte Carlo sampler to calculate the best-fitting orbital parameters and their uncertainties for each planet. We find the outer planet has a period of 1002 $\pm$ 5 days and minimum mass of 5.61 $\pm$ 0.38 Jupiter masses. We also place a 95% upper limit of 0.80 m/s/yr on long-term trends caused by additional, more distant companions.Comment: 7 pages, 1 figure, 2 tables; accepted for publication in AJ. Minor edits made after referee repor